Q2 FY2026 EarningsQ2 FY26 results were mixed, with All In revenue of $1,023M slightly beating the $1,010M consensus, while adjusted gross margin of 35.6% missed the 36.0% expectation. Adjusted EPS of $0.50 exceeded the $0.355 consensus, bolstered by a one-time gain from the Dermacosmetics divestiture and strong Infant Formula recovery (+23.1% YoY). Management reaffirmed FY26 guidance, expecting second-half performance to accelerate as manufacturing under-absorption headwinds moderate.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Perrigo(PRGO) the Revenue is 1.023 B (-3.17%), Beat estimate;the EBIT is 124.5 M (-7.91%), Beat estimate;the EPS is 0.53 (+983.3%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.02B3.17%
1.01B4.37%
+0.01B1.20%
EBITExceed expectations
0.12B7.91%
0.10B25.71%
+0.02B17.80%
EPSExceed expectations
0.53983.33%
0.36700.00%
+0.1700283.33%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf